Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Sell
32
EUZOF Quote, Financials, Valuation and Earnings
Last price:
$58.64
Seasonality move
:
6.59%
Day range:
$58.64 - $58.64
52-week range:
$58.64 - $58.64
Dividend yield:
4.45%
P/E ratio:
2.12x
P/S ratio:
11.11x
P/B ratio:
0.51x
Volume:
--
Avg. volume:
--
1-year change:
--
Market cap:
$4.2B
Revenue:
$372.1M
EPS (TTM):
-$0.92
Analysts' Opinion
-
Consensus RatingEurazeo SE has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Eurazeo SE has an estimated downside of -- from its current price of $58.64.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $58.64.
Fair Value
-
According to the consensus of 0 analysts, Eurazeo SE has -- downside to fair value with a price target of -- per share.
EUZOF vs. S&P 500
-
Over the past 5 trading days, Eurazeo SE has underperformed the S&P 500 by -1.71% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Eurazeo SE does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Eurazeo SE has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Eurazeo SE reported revenues of --.
Earnings Growth
-
Eurazeo SE has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Eurazeo SE reported earnings per share of --.
Enterprise value:
5.6B
EV / Invested capital:
--
Price / LTM sales:
11.11x
EV / EBIT:
284.58x
EV / Revenue:
14.70x
PEG ratio (5yr expected):
0.22x
EV / Free cash flow:
-126.66x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
106.43x
Gross Profit (TTM):
$145M
Return On Assets:
-0.8%
Net Income Margin (TTM):
-22.02%
Return On Equity:
-0.93%
Return On Invested Capital:
-0.84%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2005-08-31 | 2006-08-31 | 2007-08-31 | 2006-08-31 | 2007-08-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | $178,342.75 | $29,627.19 | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3.5B | $5.1B | $3.3B | $573.9M | $515.7M | |
| Total Assets | $15.7B | $17.8B | $19.3B | $10.3B | $10.3B | |
| Current Liabilities | $3B | $4.1B | $2.9B | $959.3M | $1.4B | |
| Total Liabilities | $9B | $9.7B | $10.8B | $1.2B | $1.8B | |
| Total Equity | $6.7B | $8.1B | $8.4B | $9.1B | $8.5B | |
| Total Debt | $5.2B | $4.7B | $5.5B | $667.1M | $1.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-24 | 2023-12-24 | 2023-12-24 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
EUZOF
Sector
Market Cap
$4.2B
$694.8M
Price % of 52-Week High
100%
87.67%
Dividend Yield
4.45%
2.22%
Shareholder Yield
41.37%
3.87%
1-Year Price Total Return
--
7.29%
Beta (5-Year)
0.555
0.737
Dividend yield:
4.45%
Annualized payout:
$2.43
Payout ratio:
-231.67%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$58.64
200-day SMA
Sell
Level
$58.64
Bollinger Bands (100)
Sell
Level
58.64 - 58.64
Chaikin Money Flow
Sell
Level
-32.9K
20-day SMA
Sell
Level
$58.64
Relative Strength Index (RSI14)
Sell
Level
0.00
ADX Line
Neutral
Level
Williams %R
Buy
Level
0
50-day SMA
Sell
Level
$58.64
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Sell
Level
0
On Balance Volume
Neutral
Level
11.9K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.5003)
Buy
CA Score
(Annual)
Level (0.206)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-5.1617)
Buy
Piotroski F Score
(Annual)
Level (4)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Eurazeo SE is an investment holding company operating as a conglomerate of four private equity segments. The company makes investments across a diverse array of industries and asset sizes, mostly in Europe. Eurazeo Capital, the company's greatest revenue contributor, makes investments in medium and large-sized companies above a certain asset threshold. Its other divisions consist of investments in small- and medium-sized companies, provide growth capital to smaller-sized enterprises, and make investments in real assets. The company is increasingly expanding into the Chinese, Brazilian, and American markets. Eurazeo measures performance by changes in net asset value.
Stock Forecast FAQ
In the current month, EUZOF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The EUZOF average analyst price target in the past 3 months is --.
-
Where Will Eurazeo SE Stock Be In 1 Year?
According to analysts, the consensus estimate is that Eurazeo SE share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Eurazeo SE?
Analysts are divided on their view about Eurazeo SE share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Eurazeo SE is a Sell and believe this share price will rise from its current level to --.
-
What Is Eurazeo SE's Price Target?
The price target for Eurazeo SE over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is EUZOF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Eurazeo SE is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of EUZOF?
You can purchase shares of Eurazeo SE via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Eurazeo SE shares.
-
What Is The Eurazeo SE Share Price Today?
Eurazeo SE was last trading at $58.64 per share. This represents the most recent stock quote for Eurazeo SE. Yesterday, Eurazeo SE closed at $58.64 per share.
-
How To Buy Eurazeo SE Stock Online?
In order to purchase Eurazeo SE stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
73
PSIX alert for Dec 24
Power Solutions International [PSIX] is up 19.35% over the past day.
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 8.07% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is down 1.39% over the past day.
